IMMUNOCELLULAR THERAPEUTICS LTD Common Stock
Why Robinhood?
You can watch IMUC and buy or sell other stocks, ETFs, and their options commission-free!About IMUC
ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells.
IMUC Key Statistics
Stock Snapshot
IMMUNOCELLULAR THERAPEUTICS LTD Common Stock(IMUC) stock is priced at $0.47, giving the company a market capitalization of 1.3M.
On 2026-07-25, IMMUNOCELLULAR THERAPEUTICS LTD Common Stock(IMUC) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 5.57K.
The stock's 52-week range extends from a low of $0.16 to a high of $3.20.
The stock's 52-week range extends from a low of $0.16 to a high of $3.20.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.